Purchase Order AG6538P160088
- Not listed
- Qiagen, LLC received a contract award valued at $15,686.40 for drugs and biologicals from a civilian federal agency on December 2, 2015, with an ultimate completion date of April 30, 2016. This contract was issued as a Blanket Purchase Agreement (BPA) call under firm fixed pricing, with no set-aside designation. The work will be performed in Valencia, California. Qiagen, LLC is a subsidiary of Qiagen N.V., a Netherlands-headquartered multinational biotechnology company specializing in...
- Qiagen, LLC, a subsidiary of Netherlands-based Qiagen N.V., received a $4,951.67 firm fixed-price purchase order from the Plains Area civilian agency for QIAGEN RT2 Array-Cow, SYBR/ROX Mastermix, and First Strand Kit. The contract, awarded on August 24, 2015, with an ultimate completion date of September 24, 2015, was issued without a set-aside designation, reflecting open competition in the federal marketplace. Performance of this purchase order was directed to Valencia, California, where the...
- This contract award represents a Blanket Purchase Agreement (BPA) call issued to Qiagen, LLC by the Pacific West Area civilian agency on January 18, 2018, with an ultimate completion date of February 22, 2018. The award is for $2,997.94 under a firm fixed-price contract structure with no set-aside designation. Qiagen, LLC, a foreign-owned manufacturer headquartered in Germantown, Maryland, specializes in molecular diagnostics, scientific equipment, and bioinformatics solutions. The place of...
- The U.S. government awarded a $7,748 firm fixed-price purchase order to Qiagen, LLC for inspections and service agreement support related to QIAcube instruments (models 11617 and 11623). The contract, awarded on March 20, 2015, with an ultimate completion date of September 3, 2020, will be performed in Valencia, California. The funding agency is identified as the Plains Area civilian entity. This award was made without set-aside designation, reflecting the contractor's ability to compete in...
- Qiagen, LLC received a $17,992.08 firm fixed price Blanket Purchase Agreement (BPA) call award from the Office of Logistics and Acquisition Operations, a civilian federal agency, for drugs and biologicals. The contract, awarded on June 9, 2016, with an ultimate completion date of April 30, 2017, will be performed in Valencia, California. This award carries no set-aside designation, reflecting Qiagen's ability to compete effectively in the open federal marketplace. As a child entity of Qiagen...
- Qiagen, LLC received a Blanket Purchase Agreement (BPA) call from the Pacific West Area civilian agency with a ceiling value of $1,141.16. The award, issued on February 24, 2017, with an ultimate completion date of February 22, 2018, involved two releases totaling $1,141.16 ($363.90 under Release #3 INV. 97744386 and $777.26 under Release #3 INV. 97800349). The contract utilized firm fixed pricing with no set-aside designation, allowing Qiagen to compete in the open federal marketplace....
- On November 2, 2016, the Office of Logistics and Acquisition Operations awarded a Blanket Purchase Agreement (BPA) call to Qiagen, LLC for a firm fixed price contract with a ceiling value of $5,510.88. The contract was performed in Valencia, California, and was completed by November 9, 2016. No set-aside designation was used for this procurement, indicating open competition among qualified vendors. As a subsidiary of Qiagen N.V., a multinational biotechnology company headquartered in the...
- Qiagen, LLC received a $14,995.70 firm fixed-price Blanket Purchase Agreement (BPA) call award from the Office of the Director (a civilian federal agency) on December 3, 2009, for in vitro diagnostic substances and reagents. The contract, with an ultimate completion date of December 31, 2009, was performed at Qiagen's location in Valencia, California. No set-aside designation was used for this award, reflecting the company's ability to compete in the open federal marketplace. This call...
- Qiagen, LLC received a Blanket Purchase Agreement (BPA) call order valued at $7,043.44 for laboratory supplies through the Pacific West Area civilian agency. The contract, awarded on July 22, 2015, with an ultimate completion date of December 31, 2015, was executed without a set-aside designation, allowing Qiagen to compete in the open federal marketplace. The award consisted of six separate releases totaling the ceiling value, with Release #2 Part 1 comprising the largest component at...
- Qiagen, LLC was awarded a firm fixed-price purchase order valued at $12,719.47 on June 23, 2016, for 1,000 units of QIAGEN TYPE-LT Microsatellite PCR Kit. The contract was funded by a civilian federal agency and performed at Qiagen's location in Valencia, California. No set-aside designation was applied to this award, reflecting Qiagen's competitive standing in the open federal marketplace. As a molecular diagnostics manufacturer, Qiagen supplies specialized scientific equipment and reagents...
The U.S. government awarded a firm fixed-price purchase order valued at $4,614 to Qiagen, LLC for an Intergovernmental Personnel Act (IPA) engagement with Advanced Analytics LCL (2157). The award was issued without a set-aside designation on February 11, 2016, by a civilian agency within the Plains Area region, with performance occurring in Valencia, California. Qiagen, LLC is a subsidiary of Qiagen N.V., a Netherlands-based multinational biotechnology company specializing in molecular diagnostics, sample preparation technologies, and bioinformatics solutions. Qiagen brings substantial expertise in providing scientific equipment and reagents to federal agencies including the National Institutes of Health, Centers for Disease Control and Prevention, Department of Veterans Affairs, and Department of Defense. The company maintains multiple indefinite delivery vehicles across federal agencies, including blanket purchase agreements and indefinite delivery/indefinite quantity contracts valued in the millions of dollars, through which it supplies tuberculosis testing reagents, DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, and associated maintenance services. This purchase order represents a discrete transaction leveraging Qiagen's established capabilities in advanced analytics and molecular diagnostics support.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 2/11/16 |